In a 25‑year‑old woman with estradiol 19 pg/mL, testosterone 19 ng/dL, follicle‑stimulating hormone 3.5 IU/L, and luteinizing hormone 7.4 IU/L, what is the most likely diagnosis and appropriate next steps?

Likely Diagnosis: Functional Hypothalamic Amenorrhea (FHA)

This 25-year-old woman's hormone profile—estradiol 19 pg/mL, testosterone 19 ng/dL, FSH 3.5 IU/L, and LH 7.4 IU/L—is most consistent with functional hypothalamic amenorrhea (FHA), characterized by low estradiol, low-normal gonadotropins, and an LH/FSH ratio less than 2. 1

Diagnostic Interpretation

Hormonal Pattern Analysis

• Estradiol 19 pg/mL is markedly low and confirms hypoestrogenism; values below 30 pg/mL are diagnostic of estrogen deficiency characteristic of FHA. 2
• FSH 3.5 IU/L and LH 7.4 IU/L are both low-normal, ruling out primary ovarian insufficiency (which would show FSH >35 IU/L and LH >11 IU/L). 3
• The LH/FSH ratio is 2.1, which is borderline; however, in the context of profoundly low estradiol, this pattern strongly favors FHA over PCOS. 1, 2 PCOS typically presents with normal or elevated estradiol (not low), whereas FHA shows low estradiol with low LH. 2
• Testosterone 19 ng/dL is within normal range (normal female range 20–80 ng/dL), effectively excluding hyperandrogenism and making PCOS highly unlikely. 1

Key Differentiating Features

• FHA is distinguished from PCOS by:

  • Low estradiol (<30 pg/mL) in FHA versus normal/elevated estradiol in PCOS 2
  • LH/FSH ratio typically <1 in FHA versus >2 in PCOS 1, 2
  • Absence of hyperandrogenism (normal testosterone) 1
  • Thin endometrium (<5 mm on ultrasound) in FHA versus thick endometrium in PCOS 2

• Primary ovarian insufficiency (POI) is ruled out because FSH is not elevated; POI requires FSH >35 IU/L on two separate occasions at least one month apart. 3

Essential Next Steps

Immediate Clinical Assessment

• Document detailed menstrual history for the past 6 months, including age of menarche, cycle regularity, and duration of current irregularity. 2
• Assess weight changes, eating patterns, and exercise habits to evaluate for disordered eating, excessive exercise, or Female Athlete Triad. 2
• Calculate BMI and waist-hip ratio; BMI <18.5 kg/m² strongly supports FHA, whereas BMI >25 kg/m² with central obesity (WHR >0.9) would favor PCOS. 1, 2
• Evaluate for stressors, including psychological stress, recent weight loss, or intense athletic training, all of which are common triggers for FHA. 2

Mandatory Laboratory Testing

• Obtain serum prolactin (morning resting sample) to exclude hyperprolactinemia (>20 µg/L), which can mimic FHA. 1, 2
• Measure TSH to rule out thyroid dysfunction (hypothyroidism or hyperthyroidism) as a reversible cause of amenorrhea. 1, 2
• Perform a pregnancy test to exclude pregnancy before proceeding with further hormonal evaluation. 2
• Measure mid-luteal progesterone (day 21 of a 28-day cycle or 7 days before expected menses); levels <6 nmol/L (~0.19 ng/mL) confirm anovulation. 1, 3

Imaging and Bone Health Assessment

• Pelvic ultrasound is indicated to assess endometrial thickness and ovarian morphology. 2
  • Thin endometrium (<5 mm) confirms estrogen deficiency and supports FHA. 2
  • If polycystic ovarian morphology is present despite low estradiol, this represents "FHA with polycystic ovarian morphology" (FHA-PCOM), not true PCOS. 2
• Order baseline DEXA scan to assess bone mineral density, because prolonged hypoestrogenism in FHA significantly increases osteoporosis risk. 4, 3

Metabolic Screening

• Obtain fasting glucose and lipid panel to assess metabolic risk, even though this patient's profile does not suggest PCOS. 1
• Calculate glucose/insulin ratio if insulin resistance is suspected; a ratio >4 suggests reduced insulin sensitivity, though this is more relevant in PCOS. 1

Treatment Approach for FHA

Address Underlying Causes

• Lifestyle modification is first-line therapy for FHA. 1
  • If BMI is low, weight restoration to BMI >18.5 kg/m² is essential to restore hypothalamic-pituitary-ovarian axis function. 2
  • Reduce excessive exercise if present; energy availability must exceed energy expenditure. 2
  • Address psychological stressors through counseling or cognitive-behavioral therapy. 2

Hormone Replacement Therapy

• Initiate estrogen-based hormone replacement therapy (HRT) if hypoestrogenism persists despite lifestyle modification, to prevent bone loss and cardiovascular complications. 4, 3
  • Use transdermal estradiol or oral micronized estradiol to normalize estrogen levels. 4
  • Add cyclic or continuous progestogen (micronized progesterone 100–200 mg daily or medroxyprogesterone acetate 2.5–5 mg daily) to protect the endometrium. 3
  • HRT should be continued until at least age 50 (the average age of natural menopause) to mitigate long-term health risks. 3

Bone Health Management

• Prescribe calcium 1200–1500 mg daily and vitamin D 800–1000 IU daily to support bone health. 3
• Repeat DEXA scan every 1–2 years to monitor bone density response to treatment. 3

Fertility Considerations

• If pregnancy is desired, refer to reproductive endocrinology for ovulation induction. 4, 3
  • Do NOT use clomiphene citrate in FHA, as it is ineffective and not recommended. 1
  • Pulsatile GnRH therapy or gonadotropin injections are the appropriate ovulation-induction strategies for FHA. 1
• If pregnancy is not desired, counsel on the need for contraception if menstrual cycles resume, as spontaneous ovulation can occur unpredictably. 3

Critical Pitfalls to Avoid

• Do not misdiagnose FHA as PCOS based solely on an LH/FSH ratio >2; the presence of low estradiol, absence of hyperandrogenism, and thin endometrium definitively exclude PCOS. 1, 2
• Do not assume this is early menopause (POI) without elevated FSH; FSH must be >35 IU/L on two occasions to diagnose POI. 3
• Do not delay bone density assessment; prolonged hypoestrogenism causes irreversible bone loss, and early intervention is critical. 4, 3
• Do not use clomiphene citrate for ovulation induction in FHA, as it will not work and may delay appropriate treatment. 1
• Do not overlook eating disorders or excessive exercise, as these are the most common reversible causes of FHA and must be addressed for successful treatment. 2

Specialist Referral Indications

• Refer to endocrinology or gynecology for persistently abnormal hormone levels, failure to respond to lifestyle modification, or need for HRT management. 4
• Refer to reproductive endocrinology if fertility is desired, for appropriate ovulation-induction strategies. 4, 3
• Refer to psychiatry or eating disorder specialist if disordered eating or severe psychological stressors are identified. 2